Director, Cardiovascular Research. Director, Vascular & Endo Fellowship. Professor of Medicine, MSU.Passionate about CLI Research & Innovations. Michigan
Dr. Larry J. Díaz-Sandoval is an Interventional Cardiovascular Specialist at Metro Health ? University of Michigan Health in Grand Rapids, MI. He is a Professor of Medicine at Michigan State University and currently serves as the Chair of Cardiovascular Research, Director of Endovascular Research & Interventions, and as the Director of the Vascular & Endovascular Medicine Fellowship Program. He received his Doctorate in Medicine at the Universidad Central de Venezuela, in Caracas, Venezuela, his native country. Then he moved to the United States, and completed his Internal Medicine Residency and Cardiology Fellowships at Tufts University School of Medicine and his Interventional Cardiology Fellowship at the Massachusetts General Hospital, Harvard Medical School, both in Boston. Later, he moved to Michigan where he trained in complex peripheral interventions under the tutelage of Jihad Mustapha, MD at Metro Health Hospital in Grand Rapids, where he settled as an attending since 2010. He is a current Fellow of SCAI, ACC, AHA, and SVM. He is actively involved in several committees and Task Forces at SCAI, ACC, SVM and AHA. He is the author or coauthor of more than 100 publications including original research, book chapters, review articles, editorials and Expert Consensus Statements for SCAI and AHA. He is considered a Key Opinion Leader in Critical Limb Ischemia (CLI) and lectures frequently around the country and abroad, bringing the latest innovations in the field of endovascular interventions to the forefront through his constant utilization of disruptive techniques and commitment to the highest-standard research. He is a founding member of the Board of Directors of the premier multi-specialty academic group and leader in endovascular approaches to complex peripheral arterial and venous interventions in Latinamerica: HENDOLAT (?Horizontes ENDOvasculares de LATinoamerica?).
Research Interest
1) Diagnosis, management, and innovations in the field of complex peripheral interventions and follow up of CLI patients. 2) Use of Ultrasound to optimize access, guide peripheral interventions, assess tibial artery size and recoil. 3) Study of perfusion models to assess the efficacy of tibial-pedal interventions in patients with CLI. 4) Development of novel and disruptive techniques and devices to approach and treat complex lesions in CLI patients. 5) Study of the pathophysiology of the atherosclerotic plaque in the tibiopedal arterial tree and its implications in the design of novel therapeutic approaches for the endovascular treatment of CLI. 6) Disruptive technologies, Nanobiomimicry. 7) New Oral anticoagulants. 8) Management of Carotid Stenosis.